{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:25:27Z","timestamp":1783455927031,"version":"3.55.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"DOI":"10.7759\/cureus.50042","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T14:24:50Z","timestamp":1701872690000},"source":"Crossref","is-referenced-by-count":1,"title":["A Race Against Time: Early-Onset Differentiation Syndrome Following All-Trans-Retinoic-Acid (ATRA) Therapy in Acute Promyelocytic Leukemia (AML-M3)"],"prefix":"10.7759","author":[{"given":"Kamran","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnosh","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa","family":"Kakakhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Azeem","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27513","article-title":"Acute promyelocytic leukemia (APL): a review of the literature","volume":"11","author":"Jimenez JJ","year":"2020","unstructured":"Jimenez JJ, Chale RS, Abad AC, Schally AV. Acute promyelocytic leukemia (APL): a review of the literature. Oncotarget. 2020, 11:992-1003. 10.18632\/oncotarget.27513","journal-title":"Oncotarget"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16151","article-title":"Differentiation syndrome in acute promyelocytic leukaemia","volume":"187","author":"Stahl M","year":"2019","unstructured":"Stahl M, Tallman MS. Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol. 2019, 187:157-62. 10.1111\/bjh.16151","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V92.8.2712","article-title":"Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia","volume":"92","author":"De Botton S","year":"1998","unstructured":"De Botton S, Dombret H, Sanz M, et al.. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood. 1998, 92:2712-8.","journal-title":"Blood"},{"key":"ref4","article-title":"Differentiation syndrome in patients with acute promyelocytic leukemia: what nurses need to know","volume":"46","author":"Fidler KM","year":"2020","unstructured":"Fidler KM. Differentiation syndrome in patients with acute promyelocytic leukemia: what nurses need to know. Pediatr Nurs. 2020, 46:64-9.","journal-title":"Pediatr Nurs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29531","article-title":"Role of prophylactic steroids in differentiation syndrome","volume":"14","author":"Sultana J","year":"2022","unstructured":"Sultana J, Dutta J, Mustarin S, Dey P, Roy A, Mamoon MY. Role of prophylactic steroids in differentiation syndrome. Cureus. 2022, 14:e29531. 10.7759\/cureus.29531","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2011.059","article-title":"The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature","volume":"3","author":"Montesinos P","year":"2011","unstructured":"Montesinos P, Sanz MA. The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature. Mediterr J Hematol Infect Dis. 2011, 3:e2011059. 10.4084\/MJHID.2011.059","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168617","article-title":"Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors","volume":"113","author":"Montesinos P","year":"2009","unstructured":"Montesinos P, Bergua JM, Vellenga E, et al.. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009, 113:775-83. 10.1182\/blood-2008-07-168617","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/207571-a-race-against-time-early-onset-differentiation-syndrome-following-all-trans-retinoic-acid-atra-therapy-in-acute-promyelocytic-leukemia-aml-m3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:17Z","timestamp":1707509537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/207571-a-race-against-time-early-onset-differentiation-syndrome-following-all-trans-retinoic-acid-atra-therapy-in-acute-promyelocytic-leukemia-aml-m3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.50042","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}